Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CORI

Corium International (CORI) Stock Price, News & Analysis

Corium International logo

About Corium International Stock (NASDAQ:CORI)

Advanced Chart

Key Stats

Today's Range
$12.68
$12.68
50-Day Range
N/A
52-Week Range
$7.17
$13.93
Volume
N/A
Average Volume
577,723 shs
Market Capitalization
$459.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CORI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Corium International and its competitors with MarketBeat's FREE daily newsletter.

CORI Stock News Headlines

Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social Security? What we just discovered in Washington will stun even the most seasoned insiders.
Best International Student Loans
Passive Transdermal Drug Delivery Market Share by 2031
See More Headlines

CORI Stock Analysis - Frequently Asked Questions

Corium International, Inc. (NASDAQ:CORI) posted its quarterly earnings data on Thursday, August, 9th. The biopharmaceutical company reported ($0.34) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.38) by $0.04. The biopharmaceutical company earned $7.67 million during the quarter, compared to the consensus estimate of $6.72 million. Corium International had a negative net margin of 155.21% and a negative trailing twelve-month return on equity of 276.89%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Corium International investors own include Bristol Myers Squibb (BMY), Intelsat (I), Energy Transfer (ET), Iovance Biotherapeutics (IOVA), Exelixis (EXEL), SunCoke Energy Partners (SXCP) and Cypress Semiconductor (CY).

Company Calendar

Last Earnings
8/09/2018
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CORI
CIK
1594337
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.64)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$47.79 million
Net Margins
-155.21%
Pretax Margin
N/A
Return on Equity
-276.89%
Return on Assets
-57.52%

Debt

Debt-to-Equity Ratio
2.83
Current Ratio
7.61
Quick Ratio
7.47

Sales & Book Value

Annual Sales
$31.86 million
Price / Sales
14.43
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.45 per share
Price / Book
28.18

Miscellaneous

Outstanding Shares
36,250,000
Free Float
N/A
Market Cap
$459.65 million
Optionable
Optionable
Beta
0.87
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:CORI) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners